Skip to main content
Log in

Chromosome Abnormalities and Psychotropic Drugs

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

DURING a study of chromosome abnormalities in five patients treated with d-lysergic acid diethylamide (LSD) we examined thirty patients in a mental hospital and ten hospital staff members as controls. The frequency of gaps was significantly higher in the thirty patients than in the staff members group (χ2 = 6.859, P < 0.01). When we divided the control group of patients into those treated with drugs and those not treated with drugs, we found that the frequency of gaps and breaks in the group treated with drugs was significantly higher than in the group of patients not treated with drugs (χ2 = 10.399, P < 0.005, P(Fisher) = 0.037, Table 1).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

NIELSEN, J., FRIEDRICH, U. & TSUBOI, T. Chromosome Abnormalities and Psychotropic Drugs. Nature 218, 488–489 (1968). https://doi.org/10.1038/218488b0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/218488b0

  • Springer Nature Limited

This article is cited by

Navigation